227 related articles for article (PubMed ID: 34988975)
1. Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
Hasan ZU; Ahmed I; Matin RN; Homer V; Lear JT; Ismail F; Whitmarsh T; Green AC; Thomson J; Milligan A; Hogan S; Van-de-Velde V; Mitchell-Worsford L; Kentley J; Gaunt C; Jefferson-Hulme Y; Bowden SJ; Gaunt P; Wheatley K; Proby CM; Harwood CA
Br J Dermatol; 2022 Sep; 187(3):324-337. PubMed ID: 34988975
[TBL] [Abstract][Full Text] [Related]
2. Local interventions for actinic keratosis in organ transplant recipients: a systematic review.
Heppt MV; Steeb T; Niesert AC; Zacher M; Leiter U; Garbe C; Berking C
Br J Dermatol; 2019 Jan; 180(1):43-50. PubMed ID: 30188570
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial.
Togsverd-Bo K; Halldin C; Sandberg C; Gonzalez H; Wennberg AM; Sørensen SS; Wulf HC; Haedersdal M
Br J Dermatol; 2018 Apr; 178(4):903-909. PubMed ID: 28796885
[TBL] [Abstract][Full Text] [Related]
4. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical outcomes of imiquimod 5% cream vs. diclofenac 3% gel for actinic keratosis on the face or scalp: a pooled analysis of two randomized controlled trials.
Gollnick H; Dirschka T; Ostendorf R; Kerl H; Kunstfeld R
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):82-89. PubMed ID: 31407414
[TBL] [Abstract][Full Text] [Related]
6. Use of Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Systematic Review.
Mohney L; Singh R; Grada A; Feldman S
J Drugs Dermatol; 2022 Jan; 21(1):60-65. PubMed ID: 35005863
[TBL] [Abstract][Full Text] [Related]
7. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients.
Hameetman L; Commandeur S; Bavinck JN; Wisgerhof HC; de Gruijl FR; Willemze R; Mullenders L; Tensen CP; Vrieling H
BMC Cancer; 2013 Feb; 13():58. PubMed ID: 23379751
[TBL] [Abstract][Full Text] [Related]
9. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up.
Krawtchenko N; Roewert-Huber J; Ulrich M; Mann I; Sterry W; Stockfleth E
Br J Dermatol; 2007 Dec; 157 Suppl 2():34-40. PubMed ID: 18067630
[TBL] [Abstract][Full Text] [Related]
10. A comparison of invasive squamous cell carcinoma greater than 1 year after treatment with 5-fluorouracil, imiquimod, or photodynamic therapy with aminolevulinic acid.
Cheng B; Veerabagu S; Miller CJ; Sobanko JF; Shin TM; Higgins HW; Giordano CN; Etzkorn JR
J Am Acad Dermatol; 2022 Sep; 87(3):592-596. PubMed ID: 35661760
[TBL] [Abstract][Full Text] [Related]
11. A feasibility study of microwave therapy for precancerous actinic keratosis.
Jackson DN; Hogarth FJ; Sutherland D; Holmes EM; Donnan PT; Proby CM
Br J Dermatol; 2020 Aug; 183(2):222-230. PubMed ID: 32030723
[TBL] [Abstract][Full Text] [Related]
12. Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis: A Secondary Analysis of a Randomized Clinical Trial.
Ahmady S; Jansen MHE; Nelemans PJ; Kessels JPHM; Arits AHMM; de Rooij MJM; Essers BAB; Quaedvlieg PJF; Kelleners-Smeets NWJ; Mosterd K
JAMA Dermatol; 2022 Jun; 158(6):634-640. PubMed ID: 35475852
[TBL] [Abstract][Full Text] [Related]
13. Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement.
Massey PR; Schmults CD; Li SJ; Arron ST; Asgari MM; Bouwes Bavinck JN; Billingsley E; Blalock TW; Blasdale K; Carroll BT; Carucci JA; Chong AH; Christensen SR; Chung CL; DeSimone JA; Ducroux E; Escutia-Muñoz B; Ferrándiz-Pulido C; Fox MC; Genders RE; Geusau A; Gjersvik P; Hanlon AM; Olasz Harken EB; Hofbauer GFL; Hopkins RS; Leitenberger JJ; Loss MJ; Del Marmol V; Mascaró JM; Myers SA; Nguyen BT; Oliveira WRP; Otley CC; Proby CM; Rácz E; Ruiz-Salas V; Samie FH; Seçkin D; Shah SN; Shin TM; Shumack SP; Soon SL; Stasko T; Zavattaro E; Zeitouni NC; Zwald FO; Harwood CA; Jambusaria-Pahlajani A
JAMA Dermatol; 2021 Oct; 157(10):1219-1226. PubMed ID: 34468690
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy for the prevention and treatment of actinic keratosis/squamous cell carcinoma in solid organ transplant recipients: a systematic review and meta-analysis.
Liew YCC; De Souza NNA; Sultana RG; Oh CC
J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):251-259. PubMed ID: 31394005
[TBL] [Abstract][Full Text] [Related]
15. A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands.
Jansen MHE; Kessels JPHM; Merks I; Nelemans PJ; Kelleners-Smeets NWJ; Mosterd K; Essers BAB
Br J Dermatol; 2020 Oct; 183(4):738-744. PubMed ID: 31961446
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of new class I medical device for actinic keratoses: a randomized controlled prospective study.
Veronese F; Zavattaro E; Orioni G; Landucci G; Tarantino V; Airoldi C; Savoia P
J Dermatolog Treat; 2021 Sep; 32(6):625-630. PubMed ID: 31689138
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
Schauder DM; Kim J; Nijhawan RI
JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
[TBL] [Abstract][Full Text] [Related]
18. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of topical 5% 5-fluorouracil in renal transplant recipients for the treatment of actinic keratoses.
Ingham AI; Weightman W
Australas J Dermatol; 2014 Aug; 55(3):204-8. PubMed ID: 24627952
[TBL] [Abstract][Full Text] [Related]
20. Topical photodynamic therapy with methylaminolevulinate for the treatment of actinic keratosis and reduction of photodamage in organ transplant recipients: a case-series of 16 patients.
Hasson A; Navarrete-Dechent C; Nicklas C; de la Cruz C
Indian J Dermatol Venereol Leprol; 2012; 78(4):448-53. PubMed ID: 22772615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]